Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 6, 2007, Pages 1384-1394

  Schiera, Gabriella ^a   Proia, Patrizia ^a   Alberti, Chiara ^a   Mineo, Marco ^a   Savettieri, Giovanni ^a   Di Liegro, Italia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Extracellular vesicles; FGF 2; Neurons; Shedding; VEGF

Indexed keywords

BETA1 INTEGRIN; CAMPTOTHECIN; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR SPACE; METABOLISM; NERVE CELL; PROTEIN TRANSPORT; RAT; SECRETION; SECRETORY VESICLE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ANTIGENS, CD29; ASTROCYTES; CAMPTOTHECIN; CELLS, CULTURED; EXTRACELLULAR SPACE; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEINS; NEURONS; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SECRETORY VESICLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38149108464     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00100.x     Document Type: Article

References (42)

1. Savettieri G, Di Liegro I, Catania C, Licata L, Pitarresi GL, D'Agostino S, Schiera G, De Caro V, Giandalia G, Giannola LI, Cestelli A. Neurons and ECM regulate occludin localization in brain endothelial cells. Neuroreport 2000 11 : 1081 4.
2. Cestelli A, Catania C, D'Agostino S, Di Liegro I, Licata L, Schiera G, Pitarresi GL, Savettieri G, De Caro V, Giandalia G, Giannola LI. Functional feature of a novel model of blood brain barrier: studies on permeation of test compounds. J Control Release. 2001 76 : 139 47.
3. Schiera G, Bono E, Raffa MP, Gallo A, Pitarresi GL, Di Liegro I, Savettieri G. Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. J Cell Mol Med. 2003 7 : 165 70.
4. Schiera G, Sala S, Gallo A, Raffa MP, Pitarresi GL, Savettieri G, Di Liegro I. Permeability properties of a three-cell type in vitro model of blood-brain barrier. J Cell Mol Med. 2005 9 : 373 9.
5. Schiera G, Proia P. In vitro models of blood-brain barrier formation and functioning. In : Di Liegro I, Savettieri G, editors. Molecular Bases of Neurodegeneration. KERALA : Research Signpost 2005. pp. 183 97.
6. D'Agostino S, Salomone M, Di Liegro I, Vittorelli ML. Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int J Oncol. 2006 29 : 1075 85.
7. Vittorelli ML. Shed membrane vesicles and clustering of membrane-bound proteolytic enzymes. Curr Top Dev Biol. 2003 54 : 411 32.
8. Pilzer D, Gasser O, Moskovich O, Schifferli JA, Fishelson Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol. 2005 27 : 375 87.
9. Whiteside TL. Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system Br J Cancer. 2005 92 : 209 11.
10. Dainiak N. Surface membrane-associated regulation of cell assembly, differentiation, and growth. Blood. 1991 78 : 264 76.
11. Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli ML. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol. 1994 26 : 173 80.
12. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M, Vittorelli ML. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem. 2003 278 : 51911 9.
13. Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 1998 58 : 4468 74.
14. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000 113 : 3365 74.
15. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001 166 : 7309 18.
16. Poste G, Nicolson GL. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA. 1980 77 : 399 403.
17. Ginestra A, La Placa MD, Saladino F, Cassara D, Nagase H, Vittorelli ML. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998 18 : 3433 7.
18. Taylor DD, Taylor CG, Jiang CG, Black PH. Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer. 1988 41 : 629 35.
19. Angelucci A, D'Ascenzo S, Festuccia C, Gravina GL, Bologna M, Dolo V, Pavan A. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis. 2000 18 : 163 70.
20. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated componente by endothelial cells. Am J Pathol. 2002 160 : 673 80.
21. Ancellin N, Colmont C, Su J, Mittereder N, Chae SS, Stefansson S, Liau G, Hla T. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem. 2002 22 : 6667 75.
22. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003 4 : 397 407.
23. Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A, Dolo V. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 2006 8 : 96 103.
24. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 1995 19 : 431 44.
25. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992 267 : 10931 4.
26. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 1994 86 : 356 61.
27. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res. 1992 59 : 115 65.
28. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev. 1997 18 : 26 45.
29. Ferrara N, Davis-Smith T. The biology of Vascular Endothelial Growth Factor. Endocr Rev. 1997 18 : 4 25.
30. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell. 1993 4 : 1317 26.
31. Huez I, Bornes S, Bresson D, Créancier L, Prats H. New vascular endothelial isoform generated by internal ribosomal entry site-driven CUG translation initiation. Mol Endocrinol 2001 15 : 2197 210.
32. Tee MK, Jaffe RB. A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. Biochem J. 2001 359 : 219 26.
33. Brandner B, Kurkela R, Vihko P, Kungl AJ. Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding. Biochem Biophys Res Commun. 2006 340 : 836 9.
34. Iambrechts D, Storkebaum E, Carmeliet P. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS Trends Mol Med. 2004 10 : 275 82.
35. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci. 1999 19 : 8487 97.
36. Lenhard T, Schober A, Suter-Crazzolara C, Unsicker K. Fibroblast growth factor-2 requires glial-cell-line derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Mol Cell Neurosci. 2002 20 : 181 97.
37. Rao MS, Hattiangady B, Shetty AK. Fetal hippocampal CA3 cell grafts enriched with FGF-2 and BDNF exhibit robust long-term survival and integration and suppress aberrant mossy fiber sprouting in the injured middle-aged hippocampus. Neurobiol Dis. 2006 21 : 276 90.
38. Johnson-Farley NN, Patel K, Kim D, Cowen DS. Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures. Brain Res. 2007 1154 : 40 9.
39. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fribloblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005 16 : 159 78.
40. Cestelli A, Savettieri G, Ferraro D, Vitale F. Formulation of a novel synthetic medium for selectively culturing rat CNS neurons. Dev Brain Res. 1987 22 : 219 27.
41. Savettieri G, Licata L, Catania C, Raneri R, Di Liegro I, Cestelli A. Synergistic effects of laminin and thyroid hormones on neuron polarity in culture. NeuroReport. 1999 10 : 1269 72.
42. Morris EJ, Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase- I: evidence for cell cycle-independent toxicity. J Cell Biol. 1996 134 : 757 70.